citalopram has been researched along with Intellectual Disability in 3 studies
Citalopram: A furancarbonitrile that is one of the serotonin uptake inhibitors used as an antidepressant. The drug is also effective in reducing ethanol uptake in alcoholics and is used in depressed patients who also suffer from TARDIVE DYSKINESIA in preference to tricyclic antidepressants, which aggravate dyskinesia.
citalopram : A racemate comprising equimolar amounts of (R)-citalopram and its enantiomer, escitalopram. It is used as an antidepressant, although only escitalopram is active.
1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile : A nitrile that is 1,3-dihydro-2-benzofuran-5-carbonitrile in which one of the hydrogens at position 1 is replaced by a p-fluorophenyl group, while the other is replaced by a 3-(dimethylamino)propyl group.
Intellectual Disability: Subnormal intellectual functioning which originates during the developmental period. This has multiple potential etiologies, including genetic defects and perinatal insults. Intelligence quotient (IQ) scores are commonly used to determine whether an individual has an intellectual disability. IQ scores between 70 and 79 are in the borderline range. Scores below 67 are in the disabled range. (from Joynt, Clinical Neurology, 1992, Ch55, p28)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The syndrome has been extensively described in children, but less information is available about adult patienis." | 5.31 | Wolf-Hirschhorn (4p-)syndrome in a near adult with major depression; successful treatment with citalopram. ( Moog, U; Tuinier, S; Verhoeven, WM; Wagemans, AM, 2002) |
| "The effect of citalopram was investigated in 20 mentally retarded patients suffering from a depressive disorder characterized by alterations in the domains of affectivity, motivation, motor activity and vital signs." | 3.71 | Citalopram in mentally retarded patients with depression: a long-term clinical investigation. ( Jacobs, GA; Tuinier, S; van den Berg, YW; Veendrik-Meekes, MJ; Verhoeven, WM, 2001) |
| "The syndrome has been extensively described in children, but less information is available about adult patienis." | 1.31 | Wolf-Hirschhorn (4p-)syndrome in a near adult with major depression; successful treatment with citalopram. ( Moog, U; Tuinier, S; Verhoeven, WM; Wagemans, AM, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kalapatapu, RK | 1 |
| Verhoeven, WM | 2 |
| Moog, U | 1 |
| Wagemans, AM | 1 |
| Tuinier, S | 2 |
| Veendrik-Meekes, MJ | 1 |
| Jacobs, GA | 1 |
| van den Berg, YW | 1 |
3 other studies available for citalopram and Intellectual Disability
| Article | Year |
|---|---|
Escitalopram treatment of stereotypic movement disorder in an adolescent with mitochondrial disorder and mental retardation.
Topics: Adolescent; Citalopram; Electron Transport Complex I; Humans; Intellectual Disability; Male; Mitocho | 2009 |
Wolf-Hirschhorn (4p-)syndrome in a near adult with major depression; successful treatment with citalopram.
Topics: Abnormalities, Multiple; Adolescent; Antidepressive Agents, Second-Generation; Chromosome Deletion; | 2002 |
Citalopram in mentally retarded patients with depression: a long-term clinical investigation.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Follow-Up Studies; Humans; In | 2001 |